Guidelines for community pharmacists in patients with arterial hypertension and cardiovascular risk. Consensus document (extended version)

Sabater Hernández, D; De La Sierra, A; Bellver-Monzó, O; Divisón, JA; Gorostidi, M; Perseguer-Torregosa, Z; Segura, J; Tous, S

Guidelines for community pharmacists in patients with arterial hypertension and cardiovascular risk. Consensus document (extended version)

Sabater Hernández, D

De La Sierra, A Bellver-Monzó, O Divisón, JA Gorostidi, M Perseguer-Torregosa, Z Segura, J Tous, S

Permalink

Publication Type:: Journal Article
Citation:: Ars Pharmaceutica, 2011, 52 (2), pp. 38 - 58
Issue Date:: 2011-05-30

Closed Access

	Filename	Description	Size
	4723-10063-1-PB.pdf	Published Version	3.08 MB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Sabater Hernández, D https://orcid.org/0000-0001-7419-8740	en_US
dc.contributor.author	De La Sierra, A	en_US
dc.contributor.author	Bellver-Monzó, O	en_US
dc.contributor.author	Divisón, JA	en_US
dc.contributor.author	Gorostidi, M	en_US
dc.contributor.author	Perseguer-Torregosa, Z	en_US
dc.contributor.author	Segura, J	en_US
dc.contributor.author	Tous, S	en_US
dc.date.issued	2011-05-30	en_US
dc.identifier.citation	Ars Pharmaceutica, 2011, 52 (2), pp. 38 - 58	en_US
dc.identifier.issn	0004-2927	en_US
dc.identifier.uri	http://hdl.handle.net/10453/118279
dc.description.abstract	Arterial hypertension (AH) is an important health-related problem, as responsible for an important part of cardiovascular disorders. Moreover, AH is related to the development and progression of organ damage, which has indeed a negative influence in the cardiovascular prognosis of the individual. In Spain, AH is a frequent condition, affecting about 10 millions of the adult population. Due to their accessibility and specific background on drug management, the community pharmacist could play a key role in the detection and follow-up of the hypertensive patient. To date, several guidelines on hypertension management have been released, although almost invariably have been addressed to the medical community. However, it has become more evident the need for a global management of hypertension and cardiovascular risk with the participation of several health-care providers, such as pharmacists and nurses, with the aim of improving cardiovascular prevention and the quality of life of subjects affected. The present document, particularly addressed to the community pharmacist, is intended to provide current knowledge with the aim of a better shared management of patients with hypertension and cardiovascular risk. The present document pretends to serve as a tool for currently developed programs supporting the involvement of the community pharmacy in the care of patients with hypertension and cardiovascular risk. The document has been developed after a consensus between members from the Spanish Society of Hypertension, the Spanish Society of Community Pharmacy and the Research Group on Pharmaceutical Care from the University of Granada.	en_US
dc.relation.ispartof	Ars Pharmaceutica	en_US
dc.subject.classification	Pharmacology & Pharmacy	en_US
dc.title	Guidelines for community pharmacists in patients with arterial hypertension and cardiovascular risk. Consensus document (extended version)	en_US
dc.type	Journal Article
utslib.citation.volume	2	en_US
utslib.citation.volume	52	en_US
utslib.for	1115 Pharmacology and Pharmaceutical Sciences	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Graduate School of Health
utslib.copyright.status	closed_access
pubs.issue	2	en_US
pubs.publication-status	Published	en_US
pubs.volume	52	en_US

Abstract:

Arterial hypertension (AH) is an important health-related problem, as responsible for an important part of cardiovascular disorders. Moreover, AH is related to the development and progression of organ damage, which has indeed a negative influence in the cardiovascular prognosis of the individual. In Spain, AH is a frequent condition, affecting about 10 millions of the adult population. Due to their accessibility and specific background on drug management, the community pharmacist could play a key role in the detection and follow-up of the hypertensive patient. To date, several guidelines on hypertension management have been released, although almost invariably have been addressed to the medical community. However, it has become more evident the need for a global management of hypertension and cardiovascular risk with the participation of several health-care providers, such as pharmacists and nurses, with the aim of improving cardiovascular prevention and the quality of life of subjects affected. The present document, particularly addressed to the community pharmacist, is intended to provide current knowledge with the aim of a better shared management of patients with hypertension and cardiovascular risk. The present document pretends to serve as a tool for currently developed programs supporting the involvement of the community pharmacy in the care of patients with hypertension and cardiovascular risk. The document has been developed after a consensus between members from the Spanish Society of Hypertension, the Spanish Society of Community Pharmacy and the Research Group on Pharmaceutical Care from the University of Granada.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/118279